-
Je něco špatně v tomto záznamu ?
Serum levels of aryl hydrocarbon receptor, cytochromes P450 1A1 and 1B1 in patients with exacerbated psoriasis vulgaris
M. Beránek, Z. Fiala, J. Kremláček, C. Andrýs, J. Krejsek, K. Hamáková, V. Palička, L. Borská
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- cytochrom P-450 CYP1A1 krev MeSH
- cytochrom P450 CYP1B1 krev MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- progrese nemoci * MeSH
- psoriáza krev patologie MeSH
- receptory aromatických uhlovodíků krev MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
The aryl hydrocarbon receptor (AhR) is highly expressed in psoriasis skin lesions. The aim of this study was to investigate serum concentrations of AhR, cytochromes P450 (CYP) 1A1 and 1B1 in patients with exacerbated psoriasis vulgaris treated with combined therapy of ultraviolet radiation (UVR) and crude coal tar. The analyses were performed by using enzyme-linked immunosorbent assays. Before the treatment, the patients had significantly higher serum levels of AhR and CYP1A1 than healthy controls. AhR median noticeably decreased after the therapy; nevertheless, it remained significantly higher compared to the controls. CYP1A1 levels measured before and after the therapy did not differ significantly. Serum CYP1A1 positively correlated with AhR values before and after the treatment. The serum values of CYP1B1 were very low and we did not see any differences between the study group and the control group. The study demonstrated that serum levels of AhR and CYP1A1 could indicate their immunopathological and metabolic roles in exacerbated psoriasis.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19005388
- 003
- CZ-PrNML
- 005
- 20190221142126.0
- 007
- ta
- 008
- 190205s2018 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)30394267
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Beránek, Martin, $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic; Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic $d 1968- $7 xx0044204
- 245 10
- $a Serum levels of aryl hydrocarbon receptor, cytochromes P450 1A1 and 1B1 in patients with exacerbated psoriasis vulgaris / $c M. Beránek, Z. Fiala, J. Kremláček, C. Andrýs, J. Krejsek, K. Hamáková, V. Palička, L. Borská
- 520 9_
- $a The aryl hydrocarbon receptor (AhR) is highly expressed in psoriasis skin lesions. The aim of this study was to investigate serum concentrations of AhR, cytochromes P450 (CYP) 1A1 and 1B1 in patients with exacerbated psoriasis vulgaris treated with combined therapy of ultraviolet radiation (UVR) and crude coal tar. The analyses were performed by using enzyme-linked immunosorbent assays. Before the treatment, the patients had significantly higher serum levels of AhR and CYP1A1 than healthy controls. AhR median noticeably decreased after the therapy; nevertheless, it remained significantly higher compared to the controls. CYP1A1 levels measured before and after the therapy did not differ significantly. Serum CYP1A1 positively correlated with AhR values before and after the treatment. The serum values of CYP1B1 were very low and we did not see any differences between the study group and the control group. The study demonstrated that serum levels of AhR and CYP1A1 could indicate their immunopathological and metabolic roles in exacerbated psoriasis.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a cytochrom P-450 CYP1A1 $x krev $7 D019363
- 650 _2
- $a cytochrom P450 CYP1B1 $x krev $7 D065633
- 650 12
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a psoriáza $x krev $x patologie $7 D011565
- 650 _2
- $a receptory aromatických uhlovodíků $x krev $7 D018336
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fiala, Zdeněk, $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Czech Republic $d 1955- $7 nlk19990073147
- 700 1_
- $a Kremláček, Jan, $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Králové, Charles University, Czech Republic $d 1967- $7 mzk2003171485
- 700 1_
- $a Andrýs, Ctirad, $u Institute of Clinical Immunology and Allergology, Faculty of Medicine in Hradec Králové, Charles University, Czech Republic $d 1962- $7 mzk2008430528
- 700 1_
- $a Krejsek, Jan, $u Institute of Clinical Immunology and Allergology, Faculty of Medicine in Hradec Králové, Charles University, Czech Republic $d 1958- $7 nlk19990073429
- 700 1_
- $a Hamáková, Květoslava $u Clinic of Dermal and Venereal Diseases, University Hospital Hradec Králové, Czech Republic $7 xx0064204
- 700 1_
- $a Palička, Vladimír, $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic $d 1946- $7 jn99240000830
- 700 1_
- $a Borská, Lenka $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Králové, Charles University, Czech Republic $7 nlk20060173900
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 64, č. 3 (2018), s. 97-102
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30394267 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/5873/fb2018a0013.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20190205 $b ABA008
- 991 __
- $a 20190220144001 $b ABA008
- 999 __
- $a ok $b bmc $g 1378278 $s 1043593
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 64 $c 3 $d 97-102 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20190205